Chapter 5
Cash Conversion
TBEA's reported profit does become operating cash — over FY2022–FY2025 cumulative operating cash flow ran about 1.9 times net income, so this is not an accruals story. The problem sits one line lower: a capital-spending programme now running at 2.4 times operating cash flow has pushed free cash flow to -¥12.75bn, a third straight year of deterioration [1]. The gap is filled by new debt and by fresh cash from minority shareholders, while the dividend keeps flowing.
FY2025 Free Cash Flow (¥bn)
4y Operating CF / Net Income
FY2025 Capex / Revenue
FY2025 Net Debt (¥bn)
Sources: FY2025 Annual Report, Consolidated Statement of Cash Flows [2]; net debt and ratios derived from reported financials, FY2022–FY2025.
Earnings convert to operating cash; capex takes it all
The accrual test comes out clean. In each of the last four years operating cash flow exceeded net income — by 1.4x in the FY2022 peak, and by more than 3x in the depressed FY2024 as depreciation and working-capital release cushioned a thin profit. Cumulatively, ¥69.9bn of operating cash against ¥36.7bn of attributable profit is a conversion rate a skeptic cannot fault at the earnings-quality level.
Source: derived from reported financials, FY2022–FY2025 annual reports; FY2025 and FY2024 cash flows per the Consolidated Statement of Cash Flows [3] and FY2023/FY2022 per the FY2023 report [4].
The free-cash line tells the opposite story. Operating cash flow fell from ¥25.81bn in FY2023 to ¥12.91bn in FY2024 and ¥9.33bn in FY2025 [5][6], even as attributable profit rose in FY2025. Capital expenditure moved the other way — to ¥22.08bn, its highest in the window [7]. Free cash flow has gone from +¥6.91bn to -¥4.29bn to -¥12.75bn.
Sources: FY2025 Annual Report, Consolidated Statement of Cash Flows [8]; FY2023 Annual Report [9].
Depreciation and amortization of about ¥6.51bn (derived from reported financials) sets a rough floor for maintenance spending, so most of the ¥22.08bn of capital expenditure [10] is discretionary growth capital — the polysilicon nameplate now complete (The Polysilicon Engine) and the ¥17.03bn coal-to-gas and ¥6.78bn alumina builds still running (Coal and Power). That is the two-sided point: the free-cash deficit is a choice, not a distress signal, and it reverses the year management stops building. Until then, the businesses funding the spend are earning less than they were — the same coal and polysilicon margins that fell in the prior chapters.
The working-capital build under the cash line
Part of the operating-cash decline is a balance sheet that has absorbed cash as the order book grew. Trade receivables rose to ¥19.51bn from ¥12.93bn in FY2022 — a 51% increase against essentially flat revenue [11]. Inventory climbed the same 51%, to ¥21.39bn [12]. On top of that sit ¥6.57bn of contract assets — engineering revenue recognized on a percentage-of-completion basis but not yet billed, including frontier-market projects in Tanzania and Uganda whose settlement conditions are not yet met [13].
Source: FY2025 Annual Report, Consolidated Balance Sheet [14]; FY2022–FY2023 balances from reported financials, as reported.
Counting notes receivable (¥1.65bn), receivable-financing balances (¥3.64bn), trade receivables and contract assets together, roughly ¥31bn of the group's cash is tied up in what customers and projects owe it [15]. Some of that build is genuine growth in the grid and export franchise (The Grid Franchise); part is the slower collection that comes with a larger share of frontier-market turnkey work.
How operating cash is held up
The mechanism behind operating cash deserves a direct look, because it is doing quiet work. TBEA monetizes its receivable book rather than waiting on it. In FY2025 it endorsed or discounted ¥3.71bn of bank-acceptance notes with full derecognition — moved off the balance sheet, pulling their cash forward into operations [16]. It ran a further ¥1.67bn of bill-discount borrowing [17], and one of its FY2025 bond issues earmarked ¥700m of proceeds specifically to fund a supply-chain factoring book for its trading partners [18].
None of this is improper — bank-acceptance-note discounting is routine for a Chinese industrial, and the amount has actually shrunk from about ¥5.8bn at the FY2022 peak. But it is a lever with a ceiling: operating cash is being supported by turning receivables into cash faster, not by the underlying businesses generating more of it. A reader should treat the reported ¥9.33bn of operating cash as flattered, modestly, by financing-adjacent activity rather than understated.
Watch item: trade receivables grew 51% since FY2022 on flat revenue, and ¥3.71bn of notes were endorsed or discounted off the balance sheet in FY2025. If the note-monetization lever stops growing while receivables keep building, reported operating cash flow falls further even at stable profit.
Who funds the gap
With free cash flow at -¥12.75bn and the dividend still being paid, the shortfall is covered from three places. The group took on net new debt of about ¥9.0bn — ¥27.08bn of borrowings plus ¥1.5bn of bonds against ¥19.55bn repaid [19]. It drew ¥4.59bn of fresh cash from minority shareholders of its subsidiaries — outside investors putting money directly into Xinte and the energy arms rather than into TBEA itself [20]. The balance came from running down cash, which fell ¥2.49bn to ¥25.69bn [21].
Source: FY2025 Annual Report, Consolidated Statement of Cash Flows [22].
The minority-injection line is the same structure the polysilicon chapter flagged from the other side: TBEA consolidates 100% of Xinte's debt and capex but owns two-thirds of its equity (The Polysilicon Engine). On the funding side, that asymmetry works in TBEA holders' favour — outside shareholders financed ¥4.59bn of the group's capital programme in FY2025, against ¥0.66bn a year earlier. It is real capital, but it is not TBEA's, and it comes with a claim on a third of the subsidiaries' future cash.
The dividend, the equity, and the leverage
Two clarifications matter for judging balance-sheet resilience. First, the share count. Weighted shares jumped from about 4.48bn to 5.05bn between FY2023 and FY2024, which reads like an equity raise into the capex. It was not: share capital rose from ¥3,885m at end-FY2022 to ¥5,053m at end-FY2023, matched by a reduction in capital reserve — a capitalization of reserves that raised no cash and diluted no one proportionally [23][24]. The ¥22bn capex was funded by debt and internal and minority cash, not by selling new shares to the public.
Second, the dividend is held to a set share of profit rather than defended at all costs. The FY2025 distribution is ¥0.36 per share, ¥1.81bn in total, pegged at 30.35% of attributable profit [25] — the same 30% ratio as FY2024, and well below the 64% three-year cumulative payout the group ran through the higher-earning years [26]. Management is conserving cash, not stretching to sustain a headline yield. Against that, ¥4.0bn of perpetual bonds sit inside reported equity of ¥74.4bn — securities that carry coupons and behave like debt, so a stricter lens would nudge leverage up by that amount [27].
Net debt roughly doubled in a year, from ¥8.31bn to ¥16.56bn, and total borrowings — long-term loans, bonds and leases — reached about ¥42bn from ¥27bn in FY2022 (derived from reported financials). At 22% of equity, net leverage is not yet a concern; against ¥25.69bn of cash [28] and a debt-to-equity ratio near 0.57, the group can carry the current spend. The condition that would change that read is duration: if capex stays above ¥20bn for another two or three years while coal and polysilicon margins hold at today's depressed levels, the funding mix leans harder on debt and minority capital, and the balance-sheet cushion that looks comfortable now thins out.
Consensus expects revenue to grow about 10% in FY2026, to roughly ¥107bn. Faster top-line growth does not, on its own, close a cash gap driven by capital intensity and margin — it is the capex decision and the coal and polysilicon price path, not the revenue line, that determine when free cash flow turns positive again.